Physiomics PLC PYC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX0.53
- Day Range
- GBX0.51–0.52
- 52-Week Range
- GBX0.25–0.80
- Bid/Ask
- GBX0.50 / GBX0.55
- Shares Outstanding
- 453.21M
- Market Cap
- GBX237.71M
- Volume/Avg
- 1M / 4M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.60
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Physiomics PLC is a United Kingdom-based firm that provides consulting services to biopharmaceutical companies and research institutes in the areas of outsourced modelling and simulation (quantitative pharmacology), biometrics, and data science (bioinformatics). Its business activities involve the use of industry-standard technologies and a proprietary technology platform called Virtual Tumour. The company has three service lines: Biometrics, Modelling and Simulation (Quantitative Pharmacology) and Personalised Medicine. It derives revenue from the UK, the European Union and Switzerland.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 10
- Website
- https://www.physiomics.co.uk
Valuation
|
Metric
|
PYC
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 4.05 |
Price/Sales | 1.60 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
PYC
|
|---|---|
Quick Ratio | 3.30 |
Current Ratio | 3.30 |
Interest Coverage | — |
Quick Ratio
PYC
Profitability
|
Metric
|
PYC
|
|---|---|
Return on Assets (Normalized) | −72.89% |
Return on Equity (Normalized) | −440.87% |
Return on Invested Capital (Normalized) | −96.00% |
Return on Assets
PYC
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|^qPLtg | LOCK|??rqP | $128B | |||
| Moderna Inc
MRNA
| LOCK|&@trr@& | LOCK|!p | $79B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|w#^xNh? | LOCK|@^&k | $76B | |||
| argenx SE ADR
ARGX
| LOCK|r>$%N?h | LOCK|xb | $50B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|!tjrW^! | LOCK|$$ | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|<Gq#mSn | LOCK|kY%n | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|QpM?qtKs | LOCK|z&!P | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|<%^!pG^ | LOCK|?s | $23B | |||
| Incyte Corp
INCY
| LOCK|w#!Y?h> | LOCK|K&$ | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|#FW#@Y | LOCK|^!D | $14B |
United States